Document is current
Any future updates will be listed below
-
Authors
Castoldi, Angela
Monteiro, Lauar B. https://orcid.org/0000-0003-1258-6857
van Teijlingen Bakker, Nikki
Sanin, David E. https://orcid.org/0000-0003-0188-7267
Rana, Nisha
Corrado, Mauro
Cameron, Alanna M.
Hässler, Fabian https://orcid.org/0000-0002-0038-9429
Matsushita, Mai
Caputa, George
Klein Geltink, Ramon I. https://orcid.org/0000-0003-4610-3059
Büscher, Jörg https://orcid.org/0000-0002-6547-0076
Edwards-Hicks, Joy
Pearce, Erika L. https://orcid.org/0000-0001-5592-5439
Pearce, Edward J. https://orcid.org/0000-0003-1001-9656
-
Funding
Funding for this research was provided by:
Alexander von Humboldt-Stiftung
- License Information
-
More Information
Article History
Received: 3 February 2020
Accepted: 10 July 2020
First Online: 14 August 2020
Competing interests
: E.J.P. and E.L.P. declare that they are Founders of Rheos Medicines. E.L.P. is a member of the Scientific Advisory Board of Immunomet Therapeutics. The other authors declare no competing interests.
